Your browser doesn't support javascript.
loading
Longitudinal treatment patterns with ADP receptor inhibitors after myocardial infarction: Insights from the Canadian Observational AntiPlatelet sTudy.
Bagai, Akshay; Wang, Tracy Y; Goodman, Shaun G; Fisher, Harold N; Welsh, Robert C; Dery, Jean-Pierre; Zhang, Xiang; Zhu, Yajun E; Cheema, Asim N; Dehghani, Payam; Kassam, Saleem A; Ducas, John; Brass, Neil; Kim, Hahn Hoe; Fung, Anthony; Schampaert, Erick; Quraishi, Ata Ur Rehman; Mehta, Shamir R.
Afiliación
  • Bagai A; Terrence Donnelly Heart Centre, St Michael's Hospital, University of Toronto, Toronto, ON, Canada. Electronic address: bagaia@smh.ca.
  • Wang TY; Duke Clinical Research Institute, Durham, NC, USA.
  • Goodman SG; Terrence Donnelly Heart Centre, St Michael's Hospital, University of Toronto, Toronto, ON, Canada; Canadian Heart Research Centre, Toronto, ON, Canada.
  • Fisher HN; Eli Lilly Canada Inc., Toronto, ON, Canada.
  • Welsh RC; Mazankowski Alberta Heart Institute, University of Alberta, Canadian VIGOUR Centre, Edmonton, AB, Canada.
  • Dery JP; Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Quebec, QC, Canada.
  • Zhang X; Eli Lilly and Company, Indianapolis, IN, United States.
  • Zhu YE; Eli Lilly and Company, Indianapolis, IN, United States.
  • Cheema AN; Terrence Donnelly Heart Centre, St Michael's Hospital, University of Toronto, Toronto, ON, Canada.
  • Dehghani P; Prairie Vascular Research Network, Regina Qu'Appelle Health Region, Regina, SK, Canada.
  • Kassam SA; Rouge Valley Health System, Toronto, ON, Canada.
  • Ducas J; Cardiac Sciences Program, St Boniface General Hospital, University of Manitoba, Winnipeg, MB, Canada.
  • Brass N; Royal Alexandra Hospital, Edmonton, AB, Canada.
  • Kim HH; St. Mary's General Hospital, Kitchener, ON, Canada.
  • Fung A; Vancouver General Hospital, University of British Columbia, Vancouver, BC, Canada.
  • Schampaert E; Hôpital du Sacré-Coeur de Montréal, Université de Montréal, QC, Canada.
  • Quraishi AU; Dalhousie University, Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada.
  • Mehta SR; Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada.
Int J Cardiol ; 228: 459-464, 2017 Feb 01.
Article en En | MEDLINE | ID: mdl-27870977
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de Agregación Plaquetaria / Antagonistas del Receptor Purinérgico P2 / Infarto del Miocardio Tipo de estudio: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Int J Cardiol Año: 2017 Tipo del documento: Article Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de Agregación Plaquetaria / Antagonistas del Receptor Purinérgico P2 / Infarto del Miocardio Tipo de estudio: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Int J Cardiol Año: 2017 Tipo del documento: Article Pais de publicación: Países Bajos